Concepedia

Özge Rencüzoğulları

ÖR

Statistics

Publications

7

Citations

230

H-Index

7

Active since

2018

Affiliations

Istanbul Kültür University(Current)

Gebze Technical University

Yeditepe University

University of Westminster

Özge Rencüzoğulları is an author at Istanbul Kültür University specializing in oncology, molecular oncology, and cancer cell signaling.

Publications per year

2018–2023

7

Publications

7

MiR-21 Is Required for the Epithelial–Mesenchymal Transition in MDA-MB-231 Breast Cancer Cells

Elif Damla Arısan, Özge Rencüzoğulları, Clara Cieza-Borrella et al. · International Journal of Molecular Sciences · 2021 · 73 citations · Full text

Medicine, Cancer Biology, Oncology +17

Upregulated Wnt-11 and miR-21 Expression Trigger Epithelial Mesenchymal Transition in Aggressive Prostate Cancer Cells

Elif Damla Arısan, Özge Rencüzoğulları, Inês Lua Freitas et al. · Biology · 2020 · 37 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

In situ synthesis and cell line studies of nano-hydroxyapatite/graphene oxide composite materials for bone support applications

Melike Nur Özder, Fatih Çiftçi, Özge Rencüzoğulları et al. · Ceramics International · 2023 · 36 citations · Full text

Natural Sciences, Materials Engineering, Materials Science +17

Diclofenac induced apoptosis via altering PI3K/Akt/MAPK signaling axis in HCT 116 more efficiently compared to SW480 colon cancer cells

Elif Damla Arısan, Zehragül Ergül, Gülnihal Bozdağ et al. · Molecular Biology Reports · 2018 · 34 citations

Life Sciences, Oncology, Pharmacology +14

Palbociclib, a selective CDK4/6 inhibitor, restricts cell survival and epithelial‐mesenchymal transition in Panc‐1 and MiaPaCa‐2 pancreatic cancer cells

Özge Rencüzoğulları, Pınar Obakan Yerlikaya, Ajda Çoker Gürkan et al. · Journal of Cellular Biochemistry · 2019 · 24 citations

Medicine, Oncology, Pharmacology +17

1–5 of 7